A Study of CS23546 in Subjects With Advanced Tumors

NCT06245122 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
156
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chipscreen Biosciences, Ltd.